Molecular Biology of the Cell

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E05-07-0635 on November 2, 2005

Vol. 17, Issue 1, 367-378, January 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E05-07-0635v1
17/1/367    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mazzieri, R.
Right arrow Articles by Blasi, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mazzieri, R.
Right arrow Articles by Blasi, F.

An Uncleavable uPAR Mutant Allows Dissection of Signaling Pathways in uPA-dependent Cell Migration

Roberta Mazzieri * {dagger}, Silvia D'Alessio * {dagger}, Richard Kamgang Kenmoe *, Liliana Ossowski {ddagger}, and Francesco Blasi * §

* Department of Molecular Biology and Functional Genomics, Università Vita Salute San Raffaele and S. Raffaele Scientific Institute, 20132 Milan, Italy; § FIRC Institute of Molecular Oncology, 20116 Milan, Italy; and {ddagger} Division of Hematology/Oncology, Department of Medicine, Mount Sinai School of Medicine, New York, NY 11029

Submitted July 15, 2005; Revised September 26, 2005; Accepted October 21, 2005
Monitoring Editor: Richard Assoian

Urokinase-type plasminogen activator (uPA) binding to uPAR induces migration, adhesion, and proliferation through multiple interactions with G proteins-coupled receptor FPRL1, integrins, or the epidermal growth factor (EGF) receptor (EGFR). At least two forms of uPAR are present on the cell surface: full-length and cleaved uPAR, each specifically interacting with one or more transmembrane proteins. The connection between these interactions and the effects on the signaling pathways activation is not clear. We have exploited an uPAR mutant (hcr, human cleavage resistant) to dissect the pathways involved in uPA-induced cell migration. This mutant is not cleaved by proteases, is glycosylphosphatidylinositol anchored, and binds uPA with a normal Kd. Both wild-type (wt) and hcr-uPAR are able to mediate uPA-induced migration, are constitutively associated with the EGFR, and associate with {alpha}3beta1 integrin upon uPA binding. However, they engage different pathways in response to uPA. wt-uPAR requires both integrins and FPRL1 to mediate uPA-induced migration, and association of wt-uPAR to {alpha}3beta1 results in uPAR cleavage and extracellular signal-regulated kinase (ERK) activation. On the contrary, hcr-uPAR does not activate ERK and does not engage FPRL1 or any other G protein-coupled receptor, but it activates an alternative pathway initiated by the formation of a triple complex (uPAR-{alpha}3beta1-EGFR) and resulting in the autotyrosine phosphorylation of EGFR.


This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E05-07-0635) on November 2, 2005.

Abbreviations used: EGF, epidermal growth factor; EGFR, epidermal growth factor receptor; ERK, extracellular signal-regulated kinase; hcr, human cleavage-resistant uPAR; ATF, amino-terminal fragment; GPI, glycosylphosphatidylinositol; fMLP, formyl-methyonyl-leucyl-proline; FPR, formyl-methyonyl-leucyl-proline receptor; IP, immunoprecipitation; JNK, c-Jun NH2-terminal kinase; uPA, urokinase-type plasminogen activator; uPAR, urokinase-type plasminogen activator receptor.

{dagger} These authors contributed equally to this work.

Address correspondence to: Francesco Blasi (blasi.francesco{at}hsr.it).




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
S. D'Alessio, L. Gerasi, and F. Blasi
uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro
J. Cell Sci., December 1, 2008; 121(23): 3922 - 3932.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C.-H. Tang, M. L. Hill, A. N. Brumwell, H. A. Chapman, and Y. Wei
Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with {beta}1 integrins
J. Cell Sci., November 15, 2008; 121(22): 3747 - 3756.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. M. Bernstein, S. S. Twining, D. J. Warejcka, E. Tall, and S. K. Masur
Urokinase Receptor Cleavage: A Crucial Step in Fibroblast-to-Myofibroblast Differentiation
Mol. Biol. Cell, July 1, 2007; 18(7): 2716 - 2727.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
C. D. Madsen, G. M. S. Ferraris, A. Andolfo, O. Cunningham, and N. Sidenius
uPAR-induced cell adhesion and migration: vitronectin provides the key
J. Cell Biol., June 21, 2007; 177(5): 927 - 939.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Wei, C.-H. Tang, Y. Kim, L. Robillard, F. Zhang, M. C. Kugler, and H. A. Chapman
Urokinase Receptors Are Required for {alpha}5beta1 Integrin-mediated Signaling in Tumor Cells
J. Biol. Chem., February 9, 2007; 282(6): 3929 - 3939.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2006 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.